Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Promis Neurosciences Inc (PMN)

Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Promis Neurosciences Inc SUITE 200 1920 YONGE STREET TORONTO A6 M4S 3E2 CAN

www.promisneurosciences.com P: 416-847-6898 F: 415-847-6899

Description:

ProMIS Neurosciences Inc. is a development stage biotechnology company. It focused on discovering and developing medicine therapeutics to treat neurodegenerative diseases in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company's product portfolio includes PMN310, PMN350, PMN330, PMN110, PMN120 and PMN130 which are in its pre-clinical stage. ProMIS Neurosciences Inc.is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 36,786
Enterprise Value, $K 24,186
Shares Outstanding, K 18,961
Annual Sales, $ 0 K
Annual Net Income, $ -13,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,580 K
EBIT, $ -14,260 K
EBITDA, $ -14,240 K
60-Month Beta 0.67
% of Insider Shareholders 10.30%
% of Institutional Shareholders 50.13%
Float, K 17,008
% Float 89.70%
Short Volume Ratio 0.50

Growth:

1-Year Return -68.88%
3-Year Return -78.34%
5-Year Return -82.89%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 40.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 04/01/24
Latest Earnings Date 05/20/24 [--]
Earnings Per Share ttm -1.13
EPS Growth vs. Prev Qtr 52.63%
EPS Growth vs. Prev Year 90.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-60 on 06/28/22

PMN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -141.23%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.51
Book Value/Share 0.20
Interest Coverage -65.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar